Botulinum Toxin Type A for the Management of Hidradenitis Suppurativa
January 2021
in “
PubMed
”
New to Botox? There is a guide in the encyclopedia. Read the guide → Studysummary This review discusses the pathogenesis and treatment of hidradenitis suppurativa and examines botulinum toxin type A as a potential therapeutic option, but reports no new clinical results.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by painful lesions, primarily in areas with numerous apocrine glands. The disease's etiology involves genetic, inflammatory, microbial, and lifestyle factors. Traditional treatments, including antibiotics, retinoids, biologics, and surgery, show variable efficacy. Recent reports indicated that botulinum toxin type A injections could be beneficial in managing HS. This review explored the pathogenesis, clinical manifestations, and traditional treatments of HS, and investigated botulinum toxin type A as a promising treatment option.
